Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Ahead of print

Issues

A comparison of biotin interference in routine immunoassays on the Roche Cobas 8000, Beckman Coulter DXi and Siemens Advia Centaur XPT immunoassay platforms

Shonagh Haslam
  • Corresponding author
  • Clinical Biochemistry Department, Lancashire Teaching Hospital NHS Foundation Trust, Preston PR2 9HT, UK, Phone: 01772521454, Fax: 01772522125
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jane Oakey / Andrew Brown / Susan Bradshaw / Martin Myers
  • Clinical Biochemistry Department, Lancashire Teaching Hospital NHS Foundation Trust, Preston, UK
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-04-16 | DOI: https://doi.org/10.1515/cclm-2019-0078

References

  • 1.

    Piketty M-L, Polak M, Flechtner I, Gonzales-Briceno L, Souberbielle J-C. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences. Clin Chem Lab Med 2017;55:780–8.CrossrefWeb of SciencePubMedGoogle Scholar

  • 2.

    Jenkins Colon P, Greene D. Biotin interference in clinical immunoassays. J Appl Lab Med 2018;2:952–9.Google Scholar

  • 3.

    Giovanella L, Imperiali M, Kasapic D, Ceriani L, Trimboli P. Euthyroid Graves’ disease with spurious hyperthyroidism: a diagnostic challenge. Clin Chem Lab Med 2018. doi: 10.1515/cclm-2018-0759. [Epub ahead of print].Google Scholar

  • 4.

    Katzman B, Lueke A, Donato L, Jaffe A, Baumann N. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. Clin Biochem 2018;60:11–6.CrossrefWeb of SciencePubMedGoogle Scholar

  • 5.

    Grimsey P, Frey N, Bendig G, Zitzler J, Lorenz O, Kasapic D, et al. Population pharmacokinetics of exogenous biotin and the relationship between biotin serum levels and in vitro immunoassay interference. Int J Pharmacokinet 2017;2:247–56.CrossrefGoogle Scholar

  • 6.

    Peyro Saint Paul L, Debruyne D, Bernard D, Mock DM, Defer GL. Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis. Expert Opin Metab Toxicol 2016;12:327–44.Web of ScienceCrossrefGoogle Scholar

  • 7.

    Trambas C, Lu Z, Yen T, Sikaris K. Characterisation of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays. Ann Clin Biochem 2018;55:205–15.CrossrefGoogle Scholar

  • 8.

    Piketty M, Prie D, Sedel F, Bernard D, Hercend C, Chanson P, et al. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. Clin Chem Lab Med 2017;55:817–25.Web of SciencePubMedCrossrefGoogle Scholar

About the article

Received: 2019-01-23

Accepted: 2019-03-23

Published Online: 2019-04-16


Author contributions: SH and JO designed the study and analysed the data. SH, JO, AB and SB were involved in sample analysis and data transfer. SH wrote the first draft of the manuscript. All authors edited, reviewed and approved the final manuscript. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), 20190078, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2019-0078.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in